Litcius/Paper detail

Management of biological therapies for chronic plaque psoriasis during COVID‐19 emergency in Italy

Marina Talamonti, Marco Galluzzo, Andrea Chiricozzi, Pietro Quaglino, Gabriella Fabbrocini, Paolo Gisondi, Angelo Valerio Marzano, Concetta Potenza, Andrea Conti, Alessandro Parodi, Anna Belloni Fortina, Federico Bardazzi, Giuseppe Argenziano, Franco Rongioletti, Luca Stingeni, Giuseppe Micali, Francesco Loconsole, Marina Venturini, Maria Rita Bongiorno, Claudio Feliciani, Pietro Rubegni, Paolo Amerio, Maria Concetta Fargnoli, Paolo D. Pigatto, Paola Savoia, Steven Paul Nisticò, Sandra Giustini, Andrea Carugno, Salvatore Cannavò, G. Rech, Francesca Prignano, Annamaria Offidani, M. Lombardo, Iris Zalaudek, Luca Bianchi, Ketty Peris, PSO‐BIO‐COVID study group

2020Journal of the European Academy of Dermatology and Venereology32 citationsDOIOpen Access PDF

Abstract

L. Bianchi reports personal fees from speaker and as consultant for AbbVie, Novartis, Janssen-Cilag, Pfizer, UCB and Leo Pharma, outside the submitted work. SP Cannavò has served as speaker or board member for AbbVie, Celgene, Eli Lilly, Leo Pharma, Janssen, Novartis and Sanofi Genzyme. A. Chiricozzi served as advisory board member and consultant and has received fees and speaker's honoraria or has participated in clinical trials for AbbVie, Almirall, Biogen, Fresenius Kabi, Leo Pharma, Lilly, Janssen, Novartis, Sanofi Genzyme and UCB Pharma. A. Conti served as advisory board member and consultant, and has received fees and speaker’s honoraria or has participated in clinical trials for AbbVie, Leo Pharma, Eli Lilly, Novartis, UCB Pharma, Pfizer, Sandoz, Celgene, Biogen and Janssen-Cilag. M.C. Fargnoli has served on advisory boards, received honoraria for lectures and research grants from Almirall, AbbVie, Galderma, Leo Pharma, Mylan, Medac Pharma, Celgene, Pierre Fabre, UCB, Eli Lilly, Pfizer, Janssen, Novartis, Sanofi Genzyme, Roche, Sun Pharma and MSD. P. Gisondi has been a consultant and/or speaker for AbbVie, Almirall, Celgene, Janssen, Leo pharma, Eli Lilly, Novartis, Pfizer, Sandoz and UCB. K. Peris reports personal fees for advisory board meeting from Almirall, AbbVie, Biogen, Janssen, Eli Lilly, Celgene, Galderma, Leo Pharma, Novartis, Pierre Fabre, Sanofi, Sandoz and Sun Pharma outside the conduct of the work. I. Zalaudek has been a consultant and/or speaker for Novartis, Celgene and Amgen.

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Plaque psoriasisPsoriasisMedicineIntensive care medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicDermatologyVirologyInternal medicineInfectious disease (medical specialty)DiseaseOutbreakPsoriasis: Treatment and PathogenesisCOVID-19 Clinical Research StudiesVitamin C and Antioxidants Research